Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

12 Months Ended

Aug. 31, 2022

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

11. Accounts Payable and Accrued Liabilities

		August 31				August 31
		2022				2021
		$				$
Accounts Payable
Vendors payable			57,150				59,891
Sales tax payable			31,303				-
Accrued Liabilities
Corporate tax payable			-				1,055
Vendors payable			62,996				45,000
Total			151,449				105,946